Datasets
Buyer room
INOVALON.COMManage supplier listing
Inovalon (Clinical Trial Eligibility Screener, Data Cloud / Real-World Data) — A very large longitudinal US medical- and pharmacy-claims real-world data network (fed through payer, provider and pharmacy workflow products) surfaced for trial use as a per-criterion eligibility determination: for each patient, the structured history of diagnoses, labs, prescriptions, procedures and vaccinations is evaluated against a protocol's inclusion and exclusion criteria and returns pass / fail / inconclusive per criterion, in de-identified form and in near-real time. Also licensed separately as de-identif…
supplier index read from their site
A very large longitudinal US medical- and pharmacy-claims real-world data network (fed through payer, provider and pharmacy workflow products) surfaced for trial use as a per-criterion eligibility determination: for each patient, the structured history of diagnoses, labs, prescriptions, procedures and vaccinations is evaluated against a protocol's inclusion and exclusion criteria and returns pass / fail / inconclusive per criterion, in de-identified form and in near-real time. Also licensed separately as de-identified EHR data for screening, giving claims-plus-chart breadth.
From 20 yearsAsset class EquitiesTickers IQV · CVS · CI
Sample, licence terms, pricing and eval results when Inovalon publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Inovalon, answered from this page.
Inovalon (Clinical Trial Eligibility Screener, Data Cloud / Real-World Data) — A very large longitudinal US medical- and pharmacy-claims real-world data network (fed through payer, provider and pharmacy workflow products) surfaced for trial use as a per-criterion eligibility determination: for each patient, the structured history of diagnoses, labs, prescriptions, procedures and vaccinations is evaluated against a protocol's inclusion and exclusion criteria and returns pass / fail / inconclusive per criterion, in de-identified form and in near-real time. Also licensed separately as de-identif…
Inovalon offers (Alternative, Fundamental, Reference) — Not stated on this page. Order-of-magnitude estimate: a national medical-plus-prescription claims network of this enterprise scale implies 10^10+ claim lines and comparable pharmacy dispense events annually, each longitudinally linked per patient; the eligibility product adds one pass/fail/inconclusive evaluation per patient per protocol criterion per screening run, so at production referral volumes this alone reaches 10^7-10^8 determinations a year. Request the licensable-network size and current vintage..
Automated protocol-eligibility model training and benchmarking against expert-adjudicated pass/fail/inconclusive labels; feasibility and enrolment-forecasting studies across a national payer network; protocol criteria quality analysis (which criteria are un-observable in claims and therefore always inconclusive); trial-diversity and equity analytics with geographic and demographic coverage; epidemiology, treatment-pathway and standard-of-care studies from longitudinal medical-plus-pharmacy records; site selection using observed patient supply; downstream real-world evidence and market-access analytics on the same network.
The data is with 20 years of history.
Coverage spans US; Health Care Technology, Life Sciences Tools & Services; alternative, fundamental, reference; equities.
Inovalon has not added their own details yet. Not yet on file: